A Phase I/II Clinical Trial on the Per-operative Intratumoral Administration of Myeloid Dendritic Cells Plus Ipilimumab and Nivolumab, Followed by Repeated Intracavitary Plus Intravenous Administration of Nivolumab in Patients With Recurrent Glioblastoma.
Clinical trial NCT03233152 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03233152
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-17
- Primary completion
- 2026-11-17
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.